Catalyst Wire Dossier Catalyst Wire Dossier

CKD-331

· Chong Kun Dang Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-331, covering 2022-12-20 to 2022-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia [Phase 3]

See pricing